Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Champlin

Showing results (21-30 of 217) with videos related to

Pageof 22
Sort By:
Cancer|June 16, 2004
Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myelomaAthanasios Anagnostopoulos, Ana Aleman, Gregory Ayers, et al.
Blood Advances|September 30, 2021
Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide eraJason Yeh, Laura Whited, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?Daniel Couriel, Chitra Hosing, Rima Saliba, et al.
Pediatric Blood & Cancer|December 1, 2020
Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapyDristhi Ragoonanan, Francesco Paolo Tambaro, Sajad Jawad Khazal, et al.
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityPartow Kebriaei, Susan S Kelly, Pallavi Manuri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysisGabriela Rondón, Rima M Saliba, Issa Khouri, et al.
Oncology (Williston Park, N.Y.)|February 26, 2003
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indicationsRichard Champlin, Issa Khouri, Paolo Anderlini, et al.
Journal of Biopharmaceutical Statistics|October 19, 2012
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample sizeYuan Ji, Lei Feng, Ping Liu, et al.
Infection Control and Hospital Epidemiology|January 1, 2004
Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistanceIoannis Chatzinikolaou, Hend Hanna, Linda Graviss, et al.
Cancer|June 22, 2010
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315INikolai Velev, Jorge Cortes, Richard Champlin, et al.
Pageof 22

Showing results (21-30 of 217) with videos related to

Sort By:
Pageof 22
Cancer|June 16, 2004
Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myelomaAthanasios Anagnostopoulos, Ana Aleman, Gregory Ayers, et al.
Blood Advances|September 30, 2021
Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide eraJason Yeh, Laura Whited, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?Daniel Couriel, Chitra Hosing, Rima Saliba, et al.
Pediatric Blood & Cancer|December 1, 2020
Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapyDristhi Ragoonanan, Francesco Paolo Tambaro, Sajad Jawad Khazal, et al.
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityPartow Kebriaei, Susan S Kelly, Pallavi Manuri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysisGabriela Rondón, Rima M Saliba, Issa Khouri, et al.
Oncology (Williston Park, N.Y.)|February 26, 2003
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indicationsRichard Champlin, Issa Khouri, Paolo Anderlini, et al.
Journal of Biopharmaceutical Statistics|October 19, 2012
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample sizeYuan Ji, Lei Feng, Ping Liu, et al.
Infection Control and Hospital Epidemiology|January 1, 2004
Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistanceIoannis Chatzinikolaou, Hend Hanna, Linda Graviss, et al.
Cancer|June 22, 2010
Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315INikolai Velev, Jorge Cortes, Richard Champlin, et al.
Pageof 22